Otter Creek Advisors LLC Decreases Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Otter Creek Advisors LLC lessened its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 82.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,454 shares of the medical research company's stock after selling 6,626 shares during the period. Otter Creek Advisors LLC's holdings in IQVIA were worth $345,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of IQV. First Foundation Advisors grew its stake in shares of IQVIA by 3.8% in the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company's stock worth $245,000 after acquiring an additional 43 shares during the last quarter. Invera Wealth Advisors LLC raised its holdings in IQVIA by 0.3% in the second quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company's stock worth $3,183,000 after buying an additional 46 shares during the last quarter. Covestor Ltd lifted its stake in shares of IQVIA by 45.3% in the first quarter. Covestor Ltd now owns 154 shares of the medical research company's stock worth $39,000 after buying an additional 48 shares in the last quarter. Oregon Public Employees Retirement Fund increased its position in shares of IQVIA by 0.3% during the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company's stock valued at $3,313,000 after acquiring an additional 48 shares in the last quarter. Finally, Continuum Advisory LLC raised its holdings in IQVIA by 3.3% in the 2nd quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company's stock worth $325,000 after acquiring an additional 49 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors.

Insider Buying and Selling at IQVIA

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the transaction, the insider now owns 19,536 shares of the company's stock, valued at $4,812,302.88. This represents a 6.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

IQV has been the subject of a number of research analyst reports. Redburn Atlantic started coverage on IQVIA in a report on Monday, October 14th. They issued a "buy" rating and a $276.00 target price for the company. Deutsche Bank Aktiengesellschaft decreased their target price on IQVIA from $270.00 to $265.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Robert W. Baird dropped their price target on shares of IQVIA from $256.00 to $223.00 and set a "neutral" rating on the stock in a report on Friday, November 1st. BTIG Research decreased their price objective on shares of IQVIA from $290.00 to $260.00 and set a "buy" rating for the company in a report on Friday, November 1st. Finally, Argus upgraded shares of IQVIA to a "strong-buy" rating in a report on Wednesday, July 31st. Four analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $256.50.

IQVIA Price Performance

Shares of NYSE:IQV traded up $4.22 during trading on Friday, hitting $201.82. 1,853,492 shares of the company's stock were exchanged, compared to its average volume of 1,171,385. The business's 50-day simple moving average is $223.40 and its 200 day simple moving average is $227.35. The company has a market cap of $36.63 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 1.97 and a beta of 1.51. IQVIA Holdings Inc. has a 52-week low of $187.62 and a 52-week high of $261.73. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.